Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Balamuthia mandrillaris strain:2046

ABSTRACT: Balamuthia mandrillaris strain:2046 Genome sequencing and assembly

PROVIDER: PRJNA286157 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR8980854.fastq.gz	Fastqsanger.gz
	SRR8980854_1.fastq.gz	Fastqsanger.gz
	SRR8980854_2.fastq.gz	Fastqsanger.gz
	SRR8980855_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Balamuthia mandrillaris

Project description:Balamuthia mandrillaris overview

| PRJNA292468 | ENA

Balamuthia mandrillaris strain:ITSON01

Project description:Balamuthia mandrillaris strain:ITSON01 Genome sequencing and assembly

| PRJNA975899 | ENA

Balamuthia mandrillaris strain:CDC-V039

Project description:Balamuthia mandrillaris strain:CDC-V039 Genome sequencing and assembly

| PRJNA286069 | ENA

Balamuthia mandrillaris strain:UCSF CDC:V039

Project description:Transcriptional response of Balamuthia mandrillaris to galactose, hypoxia, and nitroxoline

| PRJNA1206197 | ENA

Project description:Balamuthia mandrillaris sequencing

| PRJNA908280 | ENA

Diagnosing Balamuthia mandrillaris Encephalitis With Metagenomic Deep Sequencing.

Project description:ObjectiveIdentification of a particular cause of meningoencephalitis can be challenging owing to the myriad bacteria, viruses, fungi, and parasites that can produce overlapping clinical phenotypes, frequently delaying diagnosis and therapy. Metagenomic deep sequencing (MDS) approaches to infectious disease diagnostics are known for their ability to identify unusual or novel viruses and thus are well suited for investigating possible etiologies of meningoencephalitis.MethodsWe present the case of a 74-year-old woman with endophthalmitis followed by meningoencephalitis. MDS of her cerebrospinal fluid (CSF) was performed to identify an infectious agent.ResultsSequences aligning to Balamuthia mandrillaris ribosomal RNA genes were identified in the CSF by MDS. Polymerase chain reaction subsequently confirmed the presence of B. mandrillaris in CSF, brain tissue, and vitreous fluid from the patient's infected eye. B. mandrillaris serology and immunohistochemistry for free-living amoebas on the brain biopsy tissue were positive.InterpretationThe diagnosis was made using MDS after the patient had been hospitalized for several weeks and subjected to costly and invasive testing. MDS is a powerful diagnostic tool with the potential for rapid and unbiased pathogen identification leading to early therapeutic targeting.

| S-EPMC4624031 | biostudies-literature

Project description:Functional genomics of Balamuthia mandrillaris

| PRJNA1208996 | ENA

Brain-eating amoeba

Project description:Acanthamoeba spp., Naegleria fowleri, Balamuthia mandrillaris Genome sequencing and assembly

| PRJNA906731 | ENA

Successful Treatment of Balamuthia mandrillaris Granulomatous Amebic Encephalitis with Nitroxoline.

Project description:A patient in California, USA, with rare and usually fatal Balamuthia mandrillaris granulomatous amebic encephalitis survived after receiving treatment with a regimen that included the repurposed drug nitroxoline. Nitroxoline, which is a quinolone typically used to treat urinary tract infections, was identified in a screen for drugs with amebicidal activity against Balamuthia.

| S-EPMC9796214 | biostudies-literature

The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug design.

Project description:Balamuthia mandrillaris, a pathogenic free-living amoeba, causes cutaneous skin lesions as well as granulomatous amoebic encephalitis, a 'brain-eating' disease. As with the other known pathogenic free-living amoebas (Naegleria fowleri and Acanthamoeba species), drug discovery efforts to combat Balamuthia infections of the central nervous system are sparse; few targets have been validated or characterized at the molecular level, and little is known about the biochemical pathways necessary for parasite survival. Current treatments of encephalitis due to B. mandrillaris lack efficacy, leading to case fatality rates above 90%. Using our recently published methodology to discover potential drugs against pathogenic amoebas, we screened a collection of 85 compounds with known antiparasitic activity and identified 59 compounds that impacted the growth of Balamuthia trophozoites at concentrations below 220 µM. Since there is no fully annotated genome or proteome of B. mandrillaris, we sequenced and assembled its transcriptome from a high-throughput RNA-sequencing (RNA-Seq) experiment and located the coding sequences of the genes potentially targeted by the growth inhibitors from our compound screens. We determined the sequence of 17 of these target genes and obtained expression clones for 15 that we validated by direct sequencing. These will be used in the future in combination with the identified hits in structure guided drug discovery campaigns to develop new approaches for the treatment of Balamuthia infections.

| S-EPMC8569187 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data